Storia in 1 fonti

Ratio collects $70M for its radiopharmaceutical trials; Vogenx plans $67M IPO

Vogenx eyes $67M IPO for mizagliflozin; Ratio raises $70M for radiopharma trials; Impact Therapeutics sells senaparib rights for $486.5M; Apple Tree faces legal setback.

Raccontata da

endpoints.news

Timeline cronologica

venerdì 31 luglio 2026·endpoints.news
Ratio collects $70M for its radiopharmaceutical trials; Vogenx plans $67M IPO
Vogenx eyes $67M IPO for mizagliflozin; Ratio raises $70M for radiopharma trials; Impact Therapeutics sells senaparib rights for $486.5M; Apple Tree faces legal setback.